These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3665323)

  • 21. An abnormal gallbladder presenting as a huge, rounded photon-deficient area in radionuclide hepatobiliary imaging.
    Davis RB; Shih WJ; Stigers K; Fried A
    J Natl Med Assoc; 1993 Mar; 85(3):222-4. PubMed ID: 8474137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of prolonged fasting and total parenteral nutrition on hepatobiliary imaging with technetium-99m DISIDA.
    Sippo WC; Moreno AJ; Cabellon S; Turnbull GL
    Clin Nucl Med; 1987 Mar; 12(3):169-72. PubMed ID: 3103968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of hepatobiliary scintigraphy with 99mTc-DISIDA in neonatal cholestasis.
    Spivak W; Sarkar S; Winter D; Glassman M; Donlon E; Tucker KJ
    J Pediatr; 1987 Jun; 110(6):855-61. PubMed ID: 3585600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy.
    Gambhir SS; Hawkins RA; Huang SC; Hall TR; Busuttil RW; Phelps ME
    J Nucl Med; 1989 Sep; 30(9):1507-18. PubMed ID: 2769404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scintigraphic diagnosis of Dubin-Johnson syndrome: DISIDA is also useful.
    Pinós T; Figueras C; Herranz R
    Am J Gastroenterol; 1991 Nov; 86(11):1687-8. PubMed ID: 1951255
    [No Abstract]   [Full Text] [Related]  

  • 26. Visualization of a recanalized umbilical vein on Tc-99m disofenin cholescintigraphy.
    Warshauer D; Soldano L
    Clin Nucl Med; 1988 Aug; 13(8):621-2. PubMed ID: 3168381
    [No Abstract]   [Full Text] [Related]  

  • 27. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.
    Calvet X; Pons F; Bruix J; Bru C; Lomeña F; Herranz R; Brugera M; Faus R; Rodes J
    J Nucl Med; 1988 Dec; 29(12):1916-20. PubMed ID: 2848112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual appearance of a highly vascular lesion on Tc-99m DISIDA hepatobiliary scintigraphy.
    Makler PT; Velchik MG; Weingrad T; Mandell G; Goldstein HA
    Clin Nucl Med; 1983 Oct; 8(10):483-5. PubMed ID: 6686096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin hepatotoxicity. A rare cause of a false-positive technetium-99m DISIDA study.
    Swayne LC; Kolc J
    Clin Nucl Med; 1986 Jan; 11(1):10-2. PubMed ID: 3943237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of Tc-99m di-isopropyliminodiacetic acid by hepatocellular carcinoma: concise communication.
    Savitch I; Kew MC; Paterson A; Esser JD; Levin J
    J Nucl Med; 1983 Dec; 24(12):1119-22. PubMed ID: 6315902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 99mTc-DISIDA and 99mTc-microcolloid scintigraphy in liver transplants.
    Prat L; Puchal R; Rafecas A; Mora J; Ricart Y; Mairal L; Fabregat J; Martin-Comin J
    Transplant Proc; 1992 Feb; 24(1):147. PubMed ID: 1539216
    [No Abstract]   [Full Text] [Related]  

  • 32. Focal nodular hyperplasia of the liver: correlation of Tc-99m DISIDA "hot spot" appearance with histopathologic findings.
    Desai M; Kroop S; Sullivan J; Santaseri V; Zanzi I; Margouleff D
    Clin Nucl Med; 1989 Nov; 14(11):814-6. PubMed ID: 2598552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical and biological properties of 2,6-diisopropyl IDA labelled with 99mTc.
    Zmbova B; Djokić D; Ninković D; Obradović V; Kostić K
    Int J Rad Appl Instrum A; 1987; 38(1):35-40. PubMed ID: 3030967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technetium-99m DISIDA hepatobiliary tract imaging in pseudotumors of the liver.
    Patel CR
    Clin Nucl Med; 1987 Oct; 12(10):777-80. PubMed ID: 3119269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual liver configuration secondary to radiation therapy in childhood.
    Tobin KD; Rosenbaum RC
    Clin Nucl Med; 1988 Jan; 13(1):63-5. PubMed ID: 3349706
    [No Abstract]   [Full Text] [Related]  

  • 36. A new cholescintigraphic agent: ruthenium-97-DISIDA.
    Zanzi I; Srivastava SC; Meinken GE; Robeson W; Mausner LF; Fairchild RG; Margouleff D
    Int J Rad Appl Instrum B; 1989; 16(4):397-403. PubMed ID: 2777581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral increased activity surrounding metastatic adenocarcinoma to the liver on hepatobiliary imaging.
    Cifers RW; Makhija M
    Clin Nucl Med; 1989 Feb; 14(2):130-1. PubMed ID: 2731393
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic hot spot on both radiocolloid and hepatobiliary imaging in acute cholecystitis.
    Slavin JD; Yoosufani Z; Spencer RP
    Clin Nucl Med; 1987 Jul; 12(7):536-8. PubMed ID: 3608335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agenesis of the right lobe of the liver.
    Cesani F; Walser EM; Goodacre B; Huynh K; Ali SA; Briscoe EG
    Clin Nucl Med; 1996 Dec; 21(12):1001-2. PubMed ID: 8957632
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetic studies of DISIDA disposition. II. Clinical studies.
    Love JE; Shaffer P; Fraser IA; Staubus AE; Lott JA; Hinkle G; Carey LC; Ellison EC; Fabri PJ
    Eur J Nucl Med; 1988; 14(9-10):436-40. PubMed ID: 3215183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.